Calcium signaling in diabetic cardiomyocytes

Cell Calcium

Volumn 56, Issue 5, 2014, Pages 372-380

  Pereira, Laetitia ^a   Ruiz Hurtado, Gema ^b,c   Rueda, Angélica ^d   Mercadier, Jean Jacques ^e,f   Benitah, Jean Pierre ^e   Gómez, Ana María ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c INSTITUTO PLURIDISCIPLINAR   (Spain)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e INSERM   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Calcium; Calcium sparks; Diabetes; Ryanodine receptors; Sex related differences

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; RYANODINE RECEPTOR 2; CALCIUM; RYANODINE RECEPTOR;

CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; EXCITATION CONTRACTION COUPLING; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; FEMALE; GENETICS; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT;

ANIMALS; CALCIUM; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MICE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SEX CHARACTERISTICS;

EID: 84912522832     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.08.004     Document Type: Review

References (89)

1. Patterson C.C., Gyurus E., Rosenbauer J., Cinek O., Neu A., Schober E., Parslow R.C., Joner G., Svensson J., Castell C., Bingley P.J., Schoenle E., Jarosz-Chobot P., Urbonaite B., Rothe U., Krzisnik C., Ionescu-Tirgoviste C., Weets I., Kocova M., Stipancic G., Samardzic M., de Beaufort C.E., Green A., Dahlquist G.G., Soltesz G. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012, 55:2142-2147.
2. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., Lin J.K., Farzadfar F., Khang Y.H., Stevens G.A., Rao M., Ali M.K., Riley L.M., Robinson C.A., Ezzati M. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
3. Cohen A., Ederhy S., Boccara F. Left ventricular diastolic (dys)function in type 2 diabetes: time for a critical reappraisal. Diabetes Metab. 2007, 33:1-2.
4. Rubler S., Dlugash J., Yuceoglu Y.Z., Kumral T., Branwood A.W., Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 1972, 30:595-602.
5. Belke D.D., Swanson E.A., Dillmann W.H. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 2004, 53:3201-3208.
6. i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes 2006, 55:608-615.
7. Razeghi P., Young M.E., Cockrill T.C., Frazier O.H., Taegtmeyer H. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Circulation 2002, 106:407-411.
8. Ernande L., Derumeaux G. Diabetic cardiomyopathy: myth or reality?. Arch. Cardiovasc. Dis. 2012, 105:218-225.
9. Bers D.M. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 2008, 70:23-49.
10. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am. J. Physiol. 1983, 245:C1-C14.
11. Gómez A.M., Valdivia H.H., Cheng H., Lederer M.R., Santana L.F., Cannell M.B., McCune S.A., Altschuld R.A., Lederer W.J. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997, 276:800-806.
12. Cheng H., Lederer W.J., Cannell M.B. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 1993, 262:740-744.
13. 2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes 2006, 55:608-615.
14. 2+ homeostasis in rat heart. Diabetes 2005, 54:3082-3088.
15. Flarsheim C.E., Grupp I.L., Matlib M.A. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am. J. Physiol. 1996, 271:H192-H202.
16. Yoshioka M., Kayo T., Ikeda T., Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997, 46:887-894.
17. 2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling. Diabetes 2007, 56:2780-2789.
18. 2+ release in myocytes from streptozotocin-induced diabetic rats. J. Mol. Cell. Cardiol. 2007, 42:234-246.
19. Kranstuber A.L., Del Rio C., Biesiadecki B.J., Hamlin R.L., Ottobre J., Gyorke S., Lacombe V.A. Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling. Front. Physiol. 2012, 3:292.
20. 2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1398-H1408.
21. Depre C., Young M.E., Ying J., Ahuja H.S., Han Q., Garza N., Davies P.J., Taegtmeyer H. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J. Mol. Cell. Cardiol. 2000, 32:985-996.
22. Delucchi F., Berni R., Frati C., Cavalli S., Graiani G., Sala R., Chaponnier C., Gabbiani G., Calani L., Del Rio D., Bocchi L., Lagrasta C., Quaini F., Stilli D. Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats. PLOS ONE 2012, 7:e39836.
23. 2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-kappaB pathway. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H353-H367.
24. Dyntar D., Sergeev P., Klisic J., Ambuhl P., Schaub M.C., Donath M.Y. High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation. J. Clin. Endocrinol. Metab. 2006, 91:1961-1967.
25. Cagalinec M., Waczulikova I., Ulicna O., Chorvat D. Morphology and contractility of cardiac myocytes in early stages of streptozotocin-induced diabetes mellitus in rats. Physiol. Res. 2013, 62:489-501.
26. Singh J., Chonkar A., Bracken N., Adeghate E., Latt Z., Hussain M. Effect of streptozotocin-induced type 1 diabetes mellitus on contraction, calcium transient, and cation contents in the isolated rat heart. Ann. N. Y. Acad. Sci. 2006, 1084:178-190.
27. Nishio Y., Kashiwagi A., Ogawa T., Asahina T., Ikebuchi M., Kodama M., Shigeta Y. Increase in [3H]PN 200-110 binding to cardiac muscle membrane in streptozocin-induced diabetic rats. Diabetes 1990, 39:1064-1069.
28. 2+-channels during the development of diabetic cardiomyopathy. Mol. Cell. Biochem. 1992, 109:173-179.
29. Bergh C.H., Hjalmarson A., Sjogren K.G., Jacobsson B. The effect of diabetes on phosphatidylinositol turnover and calcium influx in myocardium. Horm. Metab. Res. 1988, 20:381-386.
30. Jourdon P., Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J. Physiol. 1993, 470:411-429.
31. Bracken N.K., Woodall A.J., Howarth F.C., Singh J. Voltage-dependence of contraction in streptozotocin-induced diabetic myocytes. Mol. Cell. Biochem. 2004, 261:235-243.
32. 2+ currents in ventricular myocytes from rats with chronic diabetes. Am. J. Physiol. 1995, 269:H1288-H1296.
33. Feuvray D., Idell-Wenger J.A., Neely J.R. Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ. Res. 1979, 44:322-329.
34. Feuvray D., Lopaschuk G.D. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc. Res. 1997, 34:113-120.
35. 2+ metabolism. Circ. Res. 1988, 62:931-940.
36. Pang Y., Hunton D.L., Bounelis P., Marchase R.B. Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes 2002, 51:3461-3467.
37. Zhu-Mauldin X., Marsh S.A., Zou L., Marchase R.B., Chatham J.C. Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes. J. Biol. Chem. 2012, 287:39094-39106.
38. Nilius B., Owsianik G. The transient receptor potential family of ion channels. Genome Biol. 2011, 12:218.
39. Watanabe H., Murakami M., Ohba T., Takahashi Y., Ito H. TRP channel and cardiovascular disease. Pharmacol. Ther. 2008, 118:337-351.
40. Song J.X., Wang L.H., Yao L., Xu C., Wei Z.H., Zheng L.R. Impaired transient receptor potential vanilloid 1 in streptozotocin-induced diabetic hearts. Int. J. Cardiol. 2009, 134:290-292.
41. Graham S., Gorin Y., Abboud H.E., Ding M., Lee D.Y., Shi H., Ding Y., Ma R. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am. J. Physiol. Cell Physiol. 2011, 301:C304-C315.
42. Buckley C.L., Stokes A.J. Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy. Channels (Austin) 2011, 5:367-374.
43. Miller B.A., Hoffman N.E., Merali S., Zhang X.Q., Wang J., Rajan S., Shanmughapriya S., Gao E., Barrero C.A., Mallilankaraman K., Song J., Gu T., Hirschler-Laszkiewicz I., Koch W.J., Feldman A.M., Madesh M., Cheung J.Y. TRPM2 channels protect against cardiac ischemia-reperfusion injury: role of mitochondria. J. Biol. Chem. 2014, 289:7615-7629.
44. Eder P., Molkentin J.D. TRPC channels as effectors of cardiac hypertrophy. Circ. Res. 2011, 108:265-272.
45. Yue Z., Zhang Y., Xie J., Jiang J., Yue L. Transient receptor potential (TRP) channels and cardiac fibrosis. Curr. Top. Med. Chem. 2013, 13:270-282.
46. Wei Z., Wang L., Han J., Song J., Yao L., Shao L., Sun Z., Zheng L. Decreased expression of transient receptor potential vanilloid 1 impairs the postischemic recovery of diabetic mouse hearts. Circ. J. 2009, 73:1127-1132.
47. Shao C.H., Tian C., Ouyang S., Moore C.J., Alomar F., Nemet I., D'Souza A., Nagai R., Kutty S., Rozanski G.J., Ramanadham S., Singh J., Bidasee K.R. Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus. Mol. Pharmacol. 2012, 82:383-399.
48. Lacombe V.A., Viatchenko-Karpinski S., Terentyev D., Sridhar A., Emani S., Bonagura J.D., Feldman D.S., Gyorke S., Carnes C.A. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R1787-R1797.
49. 2+ and adrenergic responsiveness of cardiac myocytes in streptozotocin-induced diabetes. Clin. Exp. Pharmacol. Physiol. 1999, 26:347-353.
50. 2+ channel mRNA in streptozotocin-induced diabetic rat heart. J. Mol. Cell. Cardiol. 2000, 32:655-664.
51. Zhong Y., Ahmed S., Grupp I.L., Matlib M.A. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H1137-H1147.
52. 2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes 2001, 50:2133-2138.
53. Norby F.L., Wold L.E., Duan J., Hintz K.K., Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E658-E666.
54. Bai S.Z., Sun J., Wu H., Zhang N., Li H.X., Li G.W., Li H.Z., He W., Zhang W.H., Zhao Y.J., Wang L.N., Tian Y., Yang B.F., Yang G.D., Wu L.Y., Wang R., Xu C.Q. Decrease in calcium-sensing receptor in the progress of diabetic cardiomyopathy. Diabetes Res. Clin. Pract. 2012, 95:378-385.
55. 2+ homeostasis in the development of diabetic cardiomyopathy. Cardiovasc. Diabetol. 2014, 13:75.
56. Bidasee K.R., Nallani K., Henry B., Dincer U.D., Besch H.R. Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts. Mol. Cell. Biochem. 2003, 249:113-123.
57. 2+-cycling proteins expression in type 1 diabetic rats. Appl. Physiol. Nutr. Metab. 2012, 37:53-62.
58. Yaras N., Tuncay E., Purali N., Sahinoglu B., Vassort G., Turan B. Sex-related effects on diabetes-induced alterations in calcium release in the rat heart. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3584-H3592.
59. Houser S.R. Role of RyR2 phosphorylation in heart failure and arrhythmias: protein kinase A-mediated hyperphosphorylation of the ryanodine receptor at serine 2808 does not alter cardiac contractility or cause heart failure and arrhythmias. Circ. Res. 2014, 114:1320-1327. (discussion 1327).
60. Zhang H., Makarewich C.A., Kubo H., Wang W., Duran J.M., Li Y., Berretta R.M., Koch W.J., Chen X., Gao E., Valdivia H.H., Houser S.R. Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction. Circ. Res. 2012, 110:831-840.
61. 2+ leak in mouse heart. Biochem. Biophys. Res. Commun. 2009, 390:87-92.
62. Huke S., Bers D.M. Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 2008, 376:80-85.
63. Benkusky N.A., Weber C.S., Scherman J.A., Farrell E.F., Hacker T.A., John M.C., Powers P.A., Valdivia H.H. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ. Res. 2007, 101:819-829.
64. 2+ current trigger. J. Physiol. 2004, 556:463-480.
65. Li Y., Kranias E.G., Mignery G.A., Bers D.M. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ. Res. 2002, 90:309-316.
66. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000, 101:365-376.
67. Tian C., Shao C.H., Moore C.J., Kutty S., Walseth T., DeSouza C., Bidasee K.R. Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes. Cardiovasc. Res. 2011, 91:300-309.
68. 2+ cycling defect in the diabetic heart. Heart Fail. Rev. 2014, 19:101-112.
69. Shao C.H., Wehrens X.H., Wyatt T.A., Parbhu S., Rozanski G.J., Patel K.P., Bidasee K.R. Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation. J. Appl. Physiol. (1985) 2009, 106:1280-1292.
70. Gallego M., Casis E., Izquierdo M.J., Casis O. Restoration of cardiac transient outward potassium current by norepinephrine in diabetic rats. Pflugers Arch. 2000, 441:102-107.
71. Pandit S.V., Giles W.R., Demir S.S. A mathematical model of the electrophysiological alterations in rat ventricular myocytes in type-I diabetes. Biophys. J. 2003, 84:832-841.
72. Gruden G., Giunti S., Barutta F., Chaturvedi N., Witte D.R., Tricarico M., Fuller J.H., Cavallo Perin P., Bruno G. QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care 2012, 35:125-127.
73. Lu Z., Jiang Y.P., Wu C.Y., Ballou L.M., Liu S., Carpenter E.S., Rosen M.R., Cohen I.S., Lin R.Z. Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart. Diabetes 2013, 62:4257-4265.
74. Bertoni A.G., Tsai A., Kasper E.K., Brancati F.L. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 2003, 26:2791-2795.
75. Uusitupa M.I., Mustonen J.N., Airaksinen K.E. Diabetic heart muscle disease. Ann. Med. 1990, 22:377-386.
76. 2+ signalling in young type 2 Zucker diabetic fatty rat heart. Exp. Physiol. 2011, 96:325-337.
77. 2+ transport and a changing pattern of mRNA in aged type 2 Zucker diabetic fatty rat heart. Mol. Cell. Biochem. 2012, 361:267-280.
78. 2+ current in cardiac myocytes of type 2 diabetic db/db mice by Akt and PKC-iota. J. Cardiovasc. Pharmacol. 2011, 58:439-445.
79. Salem K.A., Qureshi M.A., Sydorenko V., Parekh K., Jayaprakash P., Iqbal T., Singh J., Oz M., Adrian T.E., Howarth F.C. Effects of exercise training on excitation-contraction coupling and related mRNA expression in hearts of Goto-Kakizaki type 2 diabetic rats. Mol. Cell. Biochem. 2013, 380:83-96.
80. 2+ current. Circ. Res. 2001, 88:195-201.
81. Schaffer S.W., Mozaffari M. Abnormal mechanical function in diabetes: relation to myocardial calcium handling. Coron. Artery Dis. 1996, 7:109-115.
82. Abe T., Ohga Y., Tabayashi N., Kobayashi S., Sakata S., Misawa H., Tsuji T., Kohzuki H., Suga H., Taniguchi S., Takaki M. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H138-H148.
83. 2+-ATPase in adult rat cardiomyocytes. Biochem. Biophys. Res. Commun. 1991, 178:906-912.
84. Fredersdorf S., Thumann C., Zimmermann W.H., Vetter R., Graf T., Luchner A., Riegger G.A., Schunkert H., Eschenhagen T., Weil J. Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: in vivo and in vitro data. Cardiovasc. Diabetol. 2012, 11:57.
85. Misra T., Gilchrist J.S., Russell J.C., Pierce G.N. Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats. Am. J. Physiol. 1999, 276:H1811-H1817.
86. Erickson J.R., Pereira L., Wang L., Han G., Ferguson A., Dao K., Copeland R.J., Despa F., Hart G.W., Ripplinger C.M., Bers D.M. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 2013, 502:372-376.
87. Farrell E.F., Antaramián A., Rueda A., Gómez A.M., Valdivia H.H. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J. Biol. Chem. 2003, 278:34660-34666.
88. Suarez J., Belke D.D., Gloss B., Dieterle T., McDonough P.M., Kim Y.-K., Brunton L.L., Dillmann W.H. In vivo adenoviral transfer of sorcin reverses the cardiac contractile abnormalities of diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H68-H75.
89. 2+ in ventricular myocytes from the Goto-Kakizaki diabetic rat. Mol. Cell. Biochem. 2008, 315:69-74.